VKH
CRMD icon

Virtu KCG Holdings’s CorMedix CRMD Stock Holding History

Virtu KCG Holdings’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,322
Closed -$18K – 3201
2016
Q4 		$18K Buy
+2,322
New +$23.5K ﹤0.01% 3241
2016
Q1 		– Sell
-7,898
Closed -$80K – 2908
2015
Q4 		$80K Buy
7,898
+5,177
+190% +$59.6K ﹤0.01% 3056
2015
Q3 		$27K Buy
+2,721
New +$42K ﹤0.01% 3108
2015
Q1 		– Sell
-3,493
Closed -$33K – 3242
2014
Q4 		$33K Buy
+3,493
New +$27.8K ﹤0.01% 3519

Other funds holding CRMD

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GLRA
Gerald L. Ray & Associates Dallas, Texas $802M AUM 21.01% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Virtu KCG Holdings's CRMD Position: Q1 2017 in Review

Virtu KCG Holdings sold out of CorMedix (CRMD) in Q1 2017, closing a stake of 2,322 shares — an estimated $18K sold.

Virtu KCG Holdings first reported a position in CRMD in Q4 2014 and held it in 4 quarters. The position peaked at $80K in Q4 2015. 30 funds tracked by Wall St. Rank hold CRMD as of Q1 2017.

  • Virtu KCG Holdings reported no remaining CorMedix position as of Q1 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 2,322 CorMedix shares in Q1 2017, an estimated $18K.
  • Virtu KCG Holdings first reported a position in CorMedix in Q4 2014 and held it in 4 quarters.
  • Virtu KCG Holdings's CorMedix position peaked at $80K in Q4 2015.
  • 30 funds tracked by Wall St. Rank held CorMedix as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.